In our latest Google Plus hangout, we sat down with the founders of Modernizing Medicine, Daniel Cane and Dr. Michael Sherling to discuss their latest integration of the Modernizing Medicine EHR with IBM’s Watson. Plus, we take some time to talk about Modernizing Medicine’s unique EMA Outcomes and EMA Grand Rounds products and how they impact the way a doctor treats a patient. We finish off by dipping into the ICD-10 and Meaningful Use Stage 2 delay.
About Daniel Cane
Daniel Cane is the CEO and co-founder of Modernizing Medicine. Since founding the company in 2010, Daniel has led his team to raise a total of nearly $30M in funding and to hire almost 185 employees as he works towards his stated goal to “Modernize Medicine.” Before founding Modernizing Medicine, Daniel co-founded Blackboard Inc., raising over $100M in venture capital and in 2004 helped take the company public on the NASDAQ. In 2011, Blackboard was sold for $1.6B.
About Dr. Michael Sherling
Dr. Michael Sherling is the co-founder and Chief Medical Officer of Modernizing Medicine. A Harvard and Yale trained dermatologist, he’s led Modernizing Medicine to gain almost 25% of the US EHR market share in dermatology. Dr. Sherling is responsible for developing and designing the dermatology-based Modernizing Medicine software, and supervising the medical arm of ophthalmology, orthopedics, plastic and cosmetic surgery, otolaryngology, gastroenterology and urology software.
